Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Stefanie Kewitz-HempelLars KurchMichaela CepelovaInes VolkmerAxel SauerbreyElke ConradStephanie KnirschGabriele PöpperlDaniel SteinbachAmbros J BeerChristof M KrammCarsten-Oliver SahlmannBernhard ErdlenbruchWolf-Dieter ReinboldAndreas OdparlikOsama SabriRegine KlugeMartin Sebastian Staege

Published in: Molecular imaging and biology (2020)

MGMT polymorphism rs12917 seems to affect chemotherapy response in PHL. The prognostic value of this polymorphism should be investigated in a larger patient cohort.

Keyphrases

hodgkin lymphoma
pet ct
positron emission tomography
pet imaging
computed tomography
squamous cell carcinoma
locally advanced
radiation therapy
rectal cancer